- Home
- STRO vs FMN Comparison
STRO vs FMN Comparison
Compare STRO & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FMN
- Stock Information
- Founded
- STRO 2003
- FMN 2002
- Country
- STRO United States
- FMN United States
- Employees
- STRO N/A
- FMN N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FMN Investment Managers
- Sector
- STRO Health Care
- FMN Finance
- Exchange
- STRO Nasdaq
- FMN Nasdaq
- Market Cap
- STRO 147.6M
- FMN 127.6M
- IPO Year
- STRO 2018
- FMN N/A
- Fundamental
- Price
- STRO $1.77
- FMN $11.28
- Analyst Decision
- STRO Strong Buy
- FMN
- Analyst Count
- STRO 7
- FMN 0
- Target Price
- STRO $12.14
- FMN N/A
- AVG Volume (30 Days)
- STRO 950.7K
- FMN 22.8K
- Earning Date
- STRO 03-24-2025
- FMN 01-01-0001
- Dividend Yield
- STRO N/A
- FMN 3.86%
- EPS Growth
- STRO N/A
- FMN N/A
- EPS
- STRO N/A
- FMN N/A
- Revenue
- STRO $160,955,000.00
- FMN N/A
- Revenue This Year
- STRO N/A
- FMN N/A
- Revenue Next Year
- STRO N/A
- FMN N/A
- P/E Ratio
- STRO N/A
- FMN N/A
- Revenue Growth
- STRO 230.90
- FMN N/A
- 52 Week Low
- STRO $1.51
- FMN $9.09
- 52 Week High
- STRO $6.13
- FMN $11.31
- Technical
- Relative Strength Index (RSI)
- STRO 42.89
- FMN 60.55
- Support Level
- STRO $1.76
- FMN $11.01
- Resistance Level
- STRO $1.95
- FMN $11.30
- Average True Range (ATR)
- STRO 0.13
- FMN 0.09
- MACD
- STRO 0.00
- FMN 0.02
- Stochastic Oscillator
- STRO 41.94
- FMN 72.97
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers.. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.